Naloxonehydrochloride

Naloxonehydrochloride

357-08-4

C19H21NO4; C19H22ClNO4; C19H21NO4.ClH

(5a)-17-allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride;NALOXONE HCL; NALOXONE HYDROCHLORIDE; (5ALPHA)-4,5-EPOXY-3,14-DIHYDRO-17-(2-PROPENYL)MORPHINAN-6-ONE HYDROCHLORIDE; 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one hydrochloride; 17-allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-onehydrochloride; 17-allyl-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-onhydrochloride; en1530; l-n-allyl-14-hydroxynordihydromorphinonehydrochloride;Naloxone hydrochloride;(-)-N-Allyl-14-hydroxynordihydromorphinone hydrochloride; 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; EINECS 206-611-0; EN 15304; EN-15304; Evzio; l-N-Allyl-14-hydroxynordihydromorphinone hydrochloride; Morphinan-6-one, 17-allyl-4,5-alpha-epoxy-3,14-dihydroxy-, hydrochloride; Nalonee; Naloxone; Naloxone HCl; Naloxone hydrochloride; Narcan; Narcanti; NIH 7890; Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, hydrochloride, (-)-; UNII-F850569PQR; (5alpha)-17-Allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, hydrochloride, (5alpha)-;

327.37

206-611-0

C=CCN1CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O.Cl

1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17?,18+,19-/m1/s1

UZHSEJADLWPNLE-OGLQFSJHSA-N

2-8°C

powder

white to off-white

QD2275000

200-2050C

Soluble in water (73 mg/ml), ethanol (3.3 mg/ml), methanol (50 mg/ml) and dimethyl sulfoxide (73 mg/ml). Insoluble in ether

ethanol: 3.3 mg/mL stable for several months refrigerated if protected from light.